Costs of Neisseria meningitidis Group A Disease and Economic Impact of Vaccination in Burkina Faso

Background. Five years since the successful introduction of MenAfriVac in a mass vaccination campaign targeting 1- to 29-year-olds in Burkina Faso, consideration must be given to the optimal strategies for sustaining population protection. This study aims to estimate the economic impact of a range o...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombini, Anaïs, Trotter, Caroline, Madrid, Yvette, Karachaliou, Andromachi, Preziosi, Marie-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639502/
https://www.ncbi.nlm.nih.gov/pubmed/26553677
http://dx.doi.org/10.1093/cid/civ600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639502/
https://www.ncbi.nlm.nih.gov/pubmed/26553677
http://dx.doi.org/10.1093/cid/civ600

Ejemplares similares